Navigation Links
Polymer platform technology innovates drug delivery
Date:4/16/2013

(Edmonton) A University of Alberta researcher is thinking small to find innovative ways to improve the delivery of drugs that can be more easily administered with fewer side-effects.

Afsaneh Lavasanifar, a professor in the Faculty of Pharmacy & Pharmaceutical Sciences, has developed and patented a polymer platform technology that can carry drugs to specific areas of the body at a nanoscopic scale. The polymeric nanostructures contain an outer shell and inner core that are capable of encapsulating drugs that the body normally has a hard time absorbing and processing.

"Making drugs water soluble is a major problem in drug development," Lavasanifar says. "When drugs are not water soluble, they cannot be absorbed efficiently by the body or administered efficiently, making them ineffective."

Lavasanifar developed the polymer over three years and published her initial findings in 2006. With support from TEC Edmonton, in 2010 she launched her own company, Meros Polymers, and currently serves as vice-president and chief science officer.

The company secured a U.S. patent for the polymer late last year, with patents pending in Europe and Japan, and was recently named a semifinalist in the fast-growth category of the TEC VenturePrize.

Targeted drug delivery

In addition to solving water insolubility, the polymer could be used to target delivery of drugs in specific areas of the body. Much of Lavasanifar's research has focused on the targeted delivery of chemotherapy drugs, some of which can be harmful to organs such as the heart or kidneys.

"We can change the normal distribution of the anti-cancer drug in the body and get the drug into the tumour and away from the site where it causes toxicity," she says.

A polymer within this platform that shows unique thermo-reactive propertiesit's liquid at room temperature but turns into a gel when warmed to body temperaturehas potential applications for eye-drop drugs, antibiotics or antipsychoticsreducing the need for repeat doses or costly administration by a health professional.

A third structure within this family also has potential as a delivery system for small interfering RNA technology, or siRNA, which allows scientists to heat and silence specific genes in a cell. The siRNA technology has not yet been used as a therapeutic agent because it breaks down in the body and has a hard time entering cells.

Lavasanifar is working with other researchers on using the polymer to deliver siRNA in lab models. "Our long-term plan is to see if we can get it into clinical trials and use it for siRNA delivery in humans," she says.

Meros is working with Alberta Innovates Technology Futures to evaluate the toxicity of the polymer, a step needed for regulatory approval. Lavasanifar is confident about the results, noting the "backbone" of the polymer has been used in absorbable sutures for many years.

Moving from lab bench to boardroom was a new experience for Lavasanifar, but she credits TEC Edmonton and her colleagues at Meros for providing invaluable expertise, especially early on. The university and pharmacy faculty have been tremendously supportive of her work, she adds.

"Without the U of A's support and funding from granting agencies, I would not be able to put my ideas into action."


'/>"/>

Contact: Bryan Alary
bryan.alary@ualberta.ca
780-492-0436
University of Alberta
Source:Eurekalert

Related medicine news :

1. New electrically-conductive polymer nanoparticles can generate heat to kill colorectal cancer cells
2. Singular polymer, multiple functions
3. Top Miami Online Marketing Company OptFirst To Launch A New Online Marketing Platform
4. Tea Leaves Health Deploys NewestMovers™ Data in All Client Strategic Growth Platforms
5. Snow Creek Medical Center Adopts the HIPAA One Platform to Complete Their HIPAA Security Requirements and Protect Their Patients’ Information
6. The Body By Vi 90 Day Challenge Is Predicted to be The #1 Weight Loss and Fitness Platform in the UK as ViSalus Launches in the European Market
7. ReviMedia Commercially Launches Lead Exchange Platform LXP
8. Service Delivery Platform (SDP) Market is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets
9. CEU360.com Leverages Online Learning Technology to Provide the Most Powerful Team Education Platform
10. SocialWellth Launches Consumer mHealth Open Network Platform
11. Connect the Doc Launches Real Patient Reviews to their Online Appointment Booking Platform in Vancouver, BC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , ... February 22, 2017 , ... A product of ... seem to derive a heart-protective benefit from eating soy foods, while others do not, ... men who are able to produce equol—a substance made by some types of “good” ...
(Date:2/22/2017)... ... February 22, 2017 , ... Forty-five percent ... those report that family members or friends have also commented about their poor ... loss wear hearing aids. One reason, suggested by 89 percent of American respondents, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... Super-Sod will attend ... 26 event in Athens, Georgia. , A shift from Super-Sod’s simple Athens Home Show ... , For the booth, grass seed plant manager Chris Roquemore constructed furniture from recycled ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Social media ... especially for hospitals and health systems. Smith & Jones’ delves into this insight and ... episode, President of Smith & Jones David Vener meets up with social media strategist ...
(Date:2/22/2017)... ... February 22, 2017 , ... BrightStar Care Charleston , a ... Medical University of South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, ... on Aging is a tremendous resource in our community. We are thrilled to participate ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 2017 Research and Markets has announced ... (Thermometers - Digital, Infrared, Mercury; Trend Indicator):Analysis By Region, By Country ... ... forecasted to grow at a CAGR of 5.33% during 2016-2021 ... infectious diseases along with surging demand of digital thermometer. Apart from ...
(Date:2/22/2017)... Feb. 22, 2017 Oncternal Therapeutics, Inc., ... both rare and common malignancies, today announced the ... The company intends to use the proceeds to ... and to advance preclinical development of a new ... is a first-in-class anti-ROR1 monoclonal antibody being developed ...
(Date:2/22/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced that KCP-400 (RgIA4), a potent antagonist ... robust chronic pain relief and disease modifying effects ... the a9a10 nAChR as a new, non-opioid target ... were reported online in the February 20 th ...
Breaking Medicine Technology: